Skip to main content

1489219

“A victory for Massachusetts consumers”: Bill takes aim at rising drug prices

Patients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, including insulin for diabetes, and face no costs whatsoever for similar generic options under a compromise bill that the House and Senate whisked to Gov. Maura Healey’s desk on Monday. The bill that came out of months of private talks late Friday would also add scrutiny to pharmacy benefit managers and eliminate or cap out-of-pocket costs for drugs that treat certain chronic conditions. The branches sent the bill to Healey with just one day remaining...